Things We Do for No Reason™: Universal Venous Thromboembolism Chemoprophylaxis in Low‐Risk Hospitalized Medical Patients
Authors:
- 1 May 2021
- journal article
- research article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 16 (5) , 301-303
Abstract
Inspired by the ABIM Foundation's Choosing Wisely® campaign, the “Things We Do for No Reason™” (TWDFNR) series reviews practices that have become common parts of hospital care but may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent clear‐cut conclusions or clinical practice standards but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion.Keywords
This publication has 15 references indexed in Scilit:
- Venous Thromboembolism Prophylaxis: Inadequate and Overprophylaxis When Comparing Perceived Versus Calculated RiskMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2017
- Hospital Performance for Pharmacologic Venous Thromboembolism Prophylaxis and Rate of Venous ThromboembolismJAMA Internal Medicine, 2014
- Benefits versus risks of pharmacological prophylaxis to prevent symptomatic venous thromboembolism in unselected medical patients revisited. Meta-analysis of the medical literatureJournal of Thrombosis and Thrombolysis, 2012
- Impact of Early Mobilization Protocol on the Medical-Surgical Inpatient PopulationClinical Nurse Specialist, 2012
- Pharmacological Venous Thromboembolism Prophylaxis in Hospitalized Medical PatientsArchives of internal medicine (1960), 2007
- Prophylaxis for Thromboembolism in Hospitalized Medical PatientsNew England Journal of Medicine, 2007
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?Journal of Thrombosis and Haemostasis, 2005
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999